RVX-208: A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo
- 8 June 2010
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (23), 2580-2589
- https://doi.org/10.1016/j.jacc.2010.02.035
Abstract
No abstract availableKeywords
Funding Information
- Resverlogix Corp. (MOP-15042)
This publication has 29 references indexed in Scilit:
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJCI Insight, 2007
- Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol TransportCirculation, 2006
- Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol releaseJournal of Lipid Research, 2005
- Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol ExcretionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulationCell Metabolism, 2005
- Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-upAtherosclerosis, 2004
- Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrationsJournal of Lipid Research, 2003
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Plasma High-Density LipoproteinsNew England Journal of Medicine, 1978